My work has supported the hypothesis that abnormal maternal metabolism interacts with placental abnormalities to promote vascular dysfunction and preeclampsia. I have found that metabolic aberrations reemerge in women with a history of preeclampsia, contributing to the elevated risk of future cardiovascular disease (CVD) in this group of women.